• TAK-715 and the Evolving Landscape of p38 MAPK Inhibition

  2026-05-19

  Explore TAK-715—a potent, selective p38 MAPK inhibitor—and discover how recent structural insights redefine its use in cytokine signaling and inflammatory research. This article uniquely dissects dual-action inhibition, phosphatase targeting, and practical protocol decisions for advanced inflammation studies.

• Ibotenic Acid: Precision NMDA Receptor Agonist in Circuit Ma

  2026-05-18

  Ibotenic acid, a validated NMDA receptor agonist, is the gold standard for targeted lesioning and neural circuit interrogation in animal models of neurodegenerative disorders. This guide details optimized workflows, troubleshooting strategies, and evidence-driven enhancements leveraging APExBIO’s high-purity product.

• Inducing Embryonic Dormancy via mTOR Inhibition: Protocol In

  2026-05-18

  This article reviews a protocol enabling reversible induction of dormancy in mammalian early embryonic cells using pharmacological mTOR inhibition. The approach is noninvasive, scalable, and facilitates mechanistic studies of embryonic diapause, with potential applications in developmental biology and assisted reproduction.

• Triiodothyronine (T3) for Precision Thyroid Hormone Assays

  2026-05-17

  Triiodothyronine (T3) from APExBIO elevates thyroid hormone signaling pathway studies with unrivaled purity, documentation, and reproducibility. This article details optimized assay workflows, troubleshooting strategies, and practical insights for metabolic regulation and gene expression research.

• EdU Imaging Kits (HF594): Precision Cell Proliferation Analy

  2026-05-16

  EdU Imaging Kits (HF594) revolutionize cell proliferation assays through sensitive, artifact-free DNA synthesis detection using click chemistry. This workflow-centric guide details optimized protocols, troubleshooting strategies, and translational research impact, with direct ties to Treg cell differentiation and asthma immunometabolism.

• EZ Cap Cy5 Firefly Luciferase mRNA: Precision in Dual-Mode T

  2026-05-15

  Discover how EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) enables high-fidelity, dual-modality gene expression tracking with advanced stability and immunogenicity suppression. This in-depth analysis reveals unique best practices for maximizing translation efficiency and assay design.

• RNA Clean and Concentrator Kit: Precision RNA Purification S

  2026-05-15

  Unlock high-throughput, ultra-pure RNA isolation with the RNA Clean and Concentrator Kit—engineered for demanding workflows from in vitro transcription to advanced disease modeling. APExBIO’s platform streamlines enzymatic RNA cleanup, empowering reproducible results even in challenging sample contexts.

• Indazole/Indole Glucagon Receptor Antagonists: Synthesis and

  2026-05-14

  This study reports the design and synthesis of novel indazole- and indole-based glucagon receptor antagonists, aimed at improving glycemic control in type 2 diabetes models. The research showcases methodical structure–activity relationship investigations, including robust synthetic strategies leveraging amide bond formation, with implications for advancing peptide and bioactive molecule chemistry.

• Dual-Action p38α MAPK Inhibitors: Mechanistic Insights and I

  2026-05-14

  Recent work by Stadnicki et al. reveals that certain kinase inhibitors, including allosteric p38α MAPK inhibitors, not only block kinase activity but also accelerate activation loop dephosphorylation by phosphatases. This dual-action mechanism—demonstrated through structural and biochemical studies—offers a promising strategy to enhance inhibitor specificity and efficacy in inflammation and apoptosis research.

• SNAI1–PIK3R2/p-EphA2 Axis Drives EMT and Stemness in TETs

  2026-05-13

  This study identifies SNAI1 as a central transcriptional driver of epithelial-mesenchymal transition (EMT) and cancer stem cell-like properties in thymic epithelial tumors (TETs), acting via the PIK3R2/p-EphA2 signaling axis. Through comprehensive multi-omics and functional assays, the authors reveal new mechanistic insights and potential therapeutic targets for these rare but aggressive malignancies.

• Deciphering Metabolite Regulation of TET2 Dioxygenase Activi

  2026-05-13

  This article reviews a robust protocol integrating biochemical assays and STD NMR spectroscopy to uncover how metabolic cofactors and inhibitors modulate human TET2 dioxygenase, a pivotal epigenetic regulator. The workflow enables rigorous identification of activating and inhibitory metabolites, offering new insight into the interplay between cellular metabolism and epigenetic control.

• Recombinant Human Growth Hormone: Molecular Precision in Cho

  2026-05-12

  Discover the molecular intricacies of Recombinant Human Growth Hormone in chondrocyte biology. This article uniquely explores IGFBP2-THBS1 axis modulation and advanced research applications, offering actionable insight for growth hormone cell proliferation assays.

• Ceramide Flux Drives Autophagy in Fish Nodavirus Infection

  2026-05-12

  This study uses lipidomics to uncover how ceramide metabolism is actively remodeled during red-spotted grouper nervous necrosis virus (RGNNV) infection. By demonstrating that ceramide accumulation supports viral replication via autophagy, the work identifies sphingolipid pathways as critical mediators and potential intervention targets in viral nervous necrosis.

• Phosbind Acrylamide: Precision Phosphate-Binding Reagent for

  2026-05-11

  Phos binding reagent (Phosbind) acrylamide delivers antibody-free, high-precision protein phosphorylation analysis by exploiting phosphate-dependent mobility shifts in SDS-PAGE. Its streamlined workflow enables robust detection of signaling events, outperforming traditional phospho-specific antibody methods for proteins in the 30–130 kDa range.

• Phenothiazines Boost Macrophage Antibacterial Activity via R

  2026-05-11

  This study demonstrates that phenothiazines, including perphenazine, enhance the antibacterial response of macrophages by inducing reactive oxygen species (ROS) accumulation and autophagy. The findings provide mechanistic evidence for host-directed strategies against intracellular bacterial infections, highlighting new research avenues for dopamine D2 receptor antagonists in immunology.

16171 records 1/1079 page Next 12345 下5页 Last page